Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
Top South Korean cosmetics maker Amorepacific Corp. suffered a net loss of 58.9 billion won in the fourth quarter, increasing 1.7 percent from the 57.9 billion won a year ago, mainly due to the pandemic's impact.
According to the firm, it endured a decrease in offline and duty-free sales with the spread of COVID-19 limiting local shopping and reducing the number of inbound tourists.
However, online sales soared by about 50 percent.
The company also posted a 9.2 million won operating loss in the quarter, after enjoying a 45.9 billion won operating profit during the same period a year before. Sales plunged 13.3 percent to 1.16 trillion won during the said period.
For 2020, Amorepacific Corp. recorded a net profit of 21.9 billion won, down 90.2 percent from 2019. Operating income plunged 66.6 percent on-year to 143 billion won, as sales dropped 20.6 percent to 4.43 trillion won.
The Amorepacific Group, which includes Innisfree and Etude, logged a net income of 22 billion, down 92.2 percent from the previous year. The group's operating profit also slumped 69.8 percent on-year to 150.7 billion won, and sales plummeted 21.5 percent to 4.93 trillion won.
